HCPCS Level II
J2359
Injection, olanzapine, 0.5 mg
Codes near J2359
These sit next to J2359 in the CMS Level II file. All J codes
- J2354Injection, octreotide, non-depot form for subcutaneous or intravenous injection, 25 mcg
- J2355Injection, oprelvekin, 5 mg
- J2356Injection, tezepelumab-ekko, 1 mg
- J2357Injection, omalizumab, 5 mg
- J2358Injection, olanzapine, long-acting, 1 mg
- J2360Injection, orphenadrine citrate, up to 60 mg
- J2361Injection, depemokimab-ulaa, 1 mg
- J2370Injection, phenylephrine hcl, up to 1 ml
- J2371Injection, phenylephrine hydrochloride, 20 micrograms
- J2372Injection, phenylephrine hydrochloride (biorphen), 20 micrograms
NDC crosswalk
| NDC | Drug | Labeler | Billable units |
|---|---|---|---|
| 00121-1072-55 | Olanzapine | PAI Holdings, LLC | 20 |
| 00143-9199-01 | Olanzapine | Hikma Pharmaceuticals USA Inc. | 20 |
| 00517-0955-01 | Olanzapine | American Regent, Inc. | 20 |
| 00781-3159-72 | Olanzapine | Sandoz Inc. | 20 |
| 00781-9105-72 | Olanzapine | Sandoz Inc. | 20 |
| 39822-1800-01 | Olanzapine | XGen Pharmaceuticals DJB, Inc. | 20 |
| 55150-0308-01 | Olanzapine | Eugia US LLC | 20 |
| 68462-0952-10 | Olanzapine | Glenmark Pharmaceuticals Inc., USA | 20 |
| 72603-0181-01 | Olanzapine | Northstar RxLLC | 20 |
Source: CMS ASP NDC-HCPCS crosswalk, effective October 1, 2026 through December 31, 2026.